Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,666 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomized Trial of Nafamostat for Covid-19.
Morpeth SC, Venkatesh B, Totterdell JA, McPhee GM, Mahar RK, Jones M, Bandara M, Barina LA, Basnet BK, Bowen AC, Burke AJ, Cochrane B, Denholm JT, Dhungana A, Dore GJ, Dotel R, Duffy E, Dummer J, Foo H, Gilbey TL, Hammond NE, Hudson BJ, Jha V, Jevaji PR, John O, Joshi R, Kang G, Kaur B, Kim S, Das SK, Lau JSY, Littleford R, Marsh JA, Marschner IC, Matthews G, Maze MJ, McArthur CJ, McFadyen JD, McMahon JH, McQuilten ZK, Molton J, Mora JM, Mudaliar V, Nguyen V, O'Sullivan MVN, Pant S, Park JE, Paterson DL, Price DJ, Raymond N, Rees MA, Robinson JO, Rogers BA, Ryu WS, Sasadeusz J, Shum O, Snelling TL, Sommerville C, Trask N, Lewin SR, Hills TE, Davis JS, Roberts JA, Tong SYC. Morpeth SC, et al. Among authors: kang g. NEJM Evid. 2023 Nov;2(11):EVIDoa2300132. doi: 10.1056/EVIDoa2300132. Epub 2023 Oct 18. NEJM Evid. 2023. PMID: 38320527 Clinical Trial.
Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India.
Chaudhary A, Madhavan R, Babji S, Raju R, Syed C, Kumar A, Saravanan P, Sharon Nikitha O, Leander Xavier JV, David Chelladurai JS, Deborah AA, George A, Kang G, Rose W. Chaudhary A, et al. Among authors: kang g. Vaccine. 2023 Jul 25;41(33):4808-4822. doi: 10.1016/j.vaccine.2023.06.059. Epub 2023 Jun 23. Vaccine. 2023. PMID: 37357073 Free PMC article. Clinical Trial.
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians.
Rakshit S, Babji S, Parthiban C, Madhavan R, Adiga V, J SE, Chetan Kumar N, Ahmed A, Shivalingaiah S, Shashikumar N, V M, Johnson AR, Ramesh N, B RG, Asokan M, Mayor S, Kang G, D'souza G, Dias M, Vyakarnam A. Rakshit S, et al. Among authors: kang g. NPJ Vaccines. 2023 Sep 14;8(1):134. doi: 10.1038/s41541-023-00731-w. NPJ Vaccines. 2023. PMID: 37709772 Free PMC article.
UDHAVI Community Support During India's Second COVID-19 Wave: A Descriptive Study on a Tertiary Care Center's Pandemic Response Helpline.
Sasidharan BK, James RI, Sathyendra S, Harsh R, Jeba Sundararaj J, Ravindran V, T HMT, Ashok N, Thirunavukkarasu MM, Punitha JV, George TK, Isaac BTJ, Zechariah AJ, David SNJ, Yesupatham DP, Irodi A, Aruldas V, Keshava SN, Zachariah A, Kang G, Mammen JJ. Sasidharan BK, et al. Among authors: kang g. Glob Health Sci Pract. 2023 Oct 30;11(5):e2200315. doi: 10.9745/GHSP-D-22-00315. Print 2023 Oct 30. Glob Health Sci Pract. 2023. PMID: 37903577 Free PMC article.
Development, confirmation, and application of a seeded Escherichia coli process control organism to validate Salmonella enterica serovar Typhi environmental surveillance methods.
Philo SE, Zhou NA, Lillis LM, Raghava V, Abraham D, Kumar V, Kumar N, Rigby J, Harrison JC, Fagnant-Sperati CS, Kossik AL, Ong AQW, Swanstrom R, Burnor E, Demeke B, Beck NK, Shirai JH, Libby SJ, Boyle DS, Feasey N, Kang G, Meschke JS. Philo SE, et al. Among authors: kang g. PLoS One. 2024 May 7;19(5):e0301624. doi: 10.1371/journal.pone.0301624. eCollection 2024. PLoS One. 2024. PMID: 38713678 Free PMC article.
2,666 results